OTC Markets OTCPK - Delayed Quote USD

Guardion Health Sciences, Inc. (GHSI)

3.2200

0.0000

(0.00%)

At close: April 25 at 4:00:00 PM EDT

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Robert Neal Weingarten	Independent Chairman & Secretary	110k	--	1952
Mr. Mark Goldstone	Interim President, CEO & Director	72.5k	--	1964
Ms. Katie Cox	Chief Accounting Officer	275k	--	1970

2925 Richmond Avenue

Suite 1200

Houston, TX 77098

United States

800 873 5141 https://www.guardionhealth.com

Sector:: Healthcare
Industry:
Full Time Employees:: 9

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Guardion Health Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events Information Not Available

October 31, 2024 at 12:00 AM UTC